Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05524233 · ClinicalTrials.gov registry record · NA
Transcranial Direct Current Stimulation (tDCS)
A NA study of Brain Fog, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05524233: Completed NA study of Brain Fog, sponsored by Baylor College of Medicine.
NCT05524233 is a NA study of Brain Fog that has completed, run by Baylor College of Medicine. The registered enrollment target is 10 participants, below the 160-participant average among 6 other Brain Fog trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05524233, a NA study of Brain Fog, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Cognitive impairment refers to when an individual struggles to learn, concentrate, remember, or make decisions. This can be due to underlying neurological diseases (i.e. Alzheimer's disease, dementia, etc.), caused by viral illness (i.e. brain fog experienced by COVID-19 survivors) or physical trauma (i.e. concussion). Recent reports indicate that two out of three Americans experience some amount of cognitive impairment in their lifetime. There are a number of therapies that have been used to help address this condition. One of these is transcranial direct current stimulation (tDCS), which delivers sustained direct current to to the head area via electrodes. A number of studies have indicated that this form of therapy is safe and efficacious at inducing neuroplasticity and exciting neuronal activity. These factors can help improve aspects of cognitive functioning such as working memory, learning, and task performance. The purpose of this pilot study is to examine the acceptability and proof of concept effectiveness of a wireless, transcranial direct current stimulation for people with cognitive impairments.
Primary Outcome
The perceived ease of use of tDCS will be assessed using a subscore of the Technology Acceptance Model (TAM) questionnaire. Participants will rate the device on a 5-point Likert scale (1 = Extremely Difficult, 5 = Extremely Easy) across seven questions. The total score will range from 7 (extremely difficult) to 35 (extremely easy), with higher scores indicating greater ease of use. Questions will assess: (1) ease of use, (2) sponge preparation, (3) attaching sponges, (4) starting/stopping thera
Conditions Studied
Interventions
- DEVICE Active Transcranial Direct Stimulation
Study Locations (1)
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-09-29 |
| Est. Completion | 2023-04-17 |
| Phase | NA |
What the finished NCT05524233 record still lists
NCT05524233 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 160-participant average among 6 other Brain Fog trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Brain Fog appearing as the primary indexed condition, and to 1 intervention - of which Active Transcranial Direct Stimulation is the first listed.
NCT05524233 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05524233 about?
NCT05524233 is a clinical study titled "Transcranial Direct Current Stimulation (tDCS)". Cognitive impairment refers to when an individual struggles to learn, concentrate, remember, or make decisions. This can be due to underlying neurological diseases (i.e. Alzheimer's disease, dementia, etc.), caused by viral illness (i.e. brain fog experienced by COVID-19 survivors) or physical traum...
What is the current status of trial NCT05524233?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2022-09-29. Estimated completion is 2023-04-17.
What conditions does trial NCT05524233 study?
This clinical trial studies the following conditions: Brain Fog.
What interventions are being tested in trial NCT05524233?
The interventions under investigation include: Active Transcranial Direct Stimulation (DEVICE).
Who is sponsoring clinical trial NCT05524233?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05524233 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Fog
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Long COVID Brain Fog: Cognitive Rehabilitation Trial
RECRUITING · NA
-
A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications
RECRUITING · NA
-
Impact of a Novel Brain Longevity Supplement Containing the Postbiotic Urolithin A (Mitopure) on Cognitive Function and Related Health Outcomes
ACTIVE NOT RECRUITING · NA
-
A Pilot rTMS Trial for Neuropsychiatric Symptoms of Long-COVID
ACTIVE NOT RECRUITING · NA
-
Effect of Daily Walnut Consumption on Memory in Subjects With Long-COVID
COMPLETED · NA
-
Neural and Cognitive Consequences of COVID-19 Survival
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI